A poilot study of eribulin monotherapy in chemorefractory patients with BRAF V600E-mutant metastatic colorectal cancer
Latest Information Update: 08 Jun 2018
At a glance
- Drugs Eribulin (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- Acronyms BRAVE PILOT study
- 06 Jun 2018 Status changed from recruiting to discontinued.
- 08 Jun 2017 New trial record